Lantern Pharma logo
Lantern Pharma
LTRN | NASDAQ
Chart Builder DCF Calculator
$0.46
-$0.14 (-23.21%)
At close: Nov 10, 2026, 4:00 PM ET

Lantern Pharma Income Statement

Income statement explained
Fiscal Year
Period Ending
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
– – – – – –
– – 174.84K – – –
– – -174.84K – – –
-17.98M -22.22M -17.88M -14.43B -12.59M -5.91M
437.93K 742.36K 765.39K 204.36M 67.93K –
-17.12M -20.78M -15.96M -14.26B -12.36M -5.91M
-17.12M -20.78M -15.96M -14.26B -12.36M -5.91M
6.46M 6.09M 5.98M 5.83B 5.02M 3.66M
11.51M 16.13M 11.89M 8.6B 7.57M 2.24M
– – -174.84K – – 0
17.98M 22.22M 17.7M 14.43B 12.59M 5.91M
– – – – – –
– – – – – –
17.98M 22.22M 17.88M 14.43B 12.59M 5.91M
– – – – – –
10.9M 10.76M 10.84M 10.85M 10.9M 6.22M
10.9M 10.76M 10.84M 10.85M 10.9M 6.22M
-1.57 -1.93K -1.47 -1.31 -1.13 -0.95
-1.57 -1.93K -1.47 -1.31 -1.13 -0.95
-17.1M -20.76M -15.79M -14.26B -12.36M -5.9M
-17.12M -20.78M -15.96M -14.26B -12.36M -5.91M
17.28K 17.28K 174.84K – 6.76K 3.39K

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.